link to the podcast (with twitter card)
Embed code for the latest episode (iframe)
What's new in 2019 in multiple myeloma?
link to the episode (with twitter card)
Embed code (iframe)
3D Tumor modeling to match each myeloma patient's tumor against today's myeloma therapies
Are myeloma stem cells responsible for relapse? Dr. Frank Zhan shares his research on the presence of a potential target called CD24
Can we create an immune system profile for each myeloma patient and how does that signature impact outcomes?
How can you become your own best myeloma advocate? It means making a plan.
Let's talk about multiple myeloma in the African American community
A 50,000 patient and family study for early precursor myeloma conditions
Learn more about the new GSK antibody for relapsed/refractory multiple myeloma
Mid-Year Review for Multiple Myeloma
How to get into popular myeloma clinical trials